(Q39664639)

13 September 2017

Mast cells have a protumorigenic role in human thyroid cancer (English)

1 reference

13 September 2017

0 references

R M Melillo

1

1 reference

13 September 2017

V Guarino

2

1 reference

13 September 2017

E Avilla

3

1 reference

13 September 2017

M R Galdiero

4

1 reference

13 September 2017

F Liotti

5

1 reference

13 September 2017

N Prevete

6

1 reference

13 September 2017

F W Rossi

7

1 reference

13 September 2017

F Basolo

8

1 reference

13 September 2017

C Ugolini

9

1 reference

13 September 2017

A de Paulis

10

1 reference

13 September 2017

M Santoro

11

1 reference

13 September 2017

G Marone

12

1 reference

13 September 2017

language of work or name

English

0 references

publication date

23 August 2010

1 reference

13 September 2017

1 reference

13 September 2017

29

1 reference

13 September 2017

47

1 reference

13 September 2017

6203-6215

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.348

13 September 2017

0 references

cites work

Cancer and the chemokine network

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Inflammation and cancer: The oncogene-driven connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Establishment of an immature mast cell line from a patient with mast cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Long-term culture and functional characterization of follicular cells from adult normal human thyroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Expression and functions of the vascular endothelial growth factors and their receptors in human basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Pathologic features of Hashimoto's-associated papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Integrated signalling pathways for mast-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

New developments in mast cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Histamine and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Role of chemokines in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Histamine as an autocrine growth factor: an unusual role for a widespread mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

BRAF is a therapeutic target in aggressive thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Mast cells: the Jekyll and Hyde of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Role of human mast cells and basophils in bronchial asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.348

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.348

1 reference

13 September 2017

1 reference